文献速递关节外科

AAHKS会员膝关节骨关节炎关节内皮质类固醇注射实践调查

Common Practices in Intra-Articular Corticosteroid Injection for the Treatment of Knee Osteoarthritis: A Survey of the American Association of Hip and Knee Surgeons Membership.
PubMed 文献 · J Arthroplasty · 2020-10-08

该研究通过22题问卷调查了美国髋膝关节外科医师协会(AAHKS)会员对膝关节骨关节炎关节内皮质类固醇注射(ICI)的实践与认知,共537/2365名会员(22.7%)回复。结果显示所有受访者均在临床中使用ICI,多数认为注射间隔至少三个月且术前应等待三个月,但注射次数上限、激素种类及配制方法差异较大。

要点

  • 所有受访AAHKS会员均在临床中使用关节内皮质类固醇注射治疗膝关节骨关节炎。
  • 多数会员认为注射间绝对最短间隔为三个月,且术前应等待三个月再手术。
  • 激素种类选择差异大:甲泼尼龙42%、曲安奈德41%、倍他米松13.3%、地塞米松3.7%。

核心结论

  • 多数完成调查的AAHKS会员常规使用关节内皮质类固醇注射治疗膝关节骨关节炎,且认为其有效但随连续注射疗效下降。
  • 多数认为注射间绝对最短间隔为三个月,无明确终身注射次数上限,并强烈共识术前应间隔三个月。
  • 激素配方、局部麻醉药及皮肤准备技术差异很大。

研究设计与样本

  • 基于Likert量表的22题问卷调查,由AAHKS研究委员会批准并于2019年春季会议期间通过电子邮件发给会员。
  • 数据用REDCap软件管理,回复会员537/2365名(22.7%)。

主要发现

  • 所有受访者均在临床中使用关节内皮质类固醇注射。
  • 多数使用三个月最短间隔,但偏好间隔更长;术前等待三个月接近共识。
  • 允许的注射次数差异很大,术前注射非常普遍。
  • 几乎所有受访者将局部麻醉药与激素混合注射,但激素种类差异大:甲泼尼龙42%、曲安奈德41%、倍他米松13.3%、地塞米松3.7%。

关键数值与推荐

  • 注射间绝对最短间隔:多数认为三个月。
  • 术前注射间隔:强烈共识为三个月。
  • 激素使用比例:甲泼尼龙42%、曲安奈德41%、倍他米松13.3%、地塞米松3.7%。

临床怎么用

  • 调查结果可反映AAHKS会员对膝关节骨关节炎关节内皮质类固醇注射的频率、配方、术前间隔等实践差异,供临床参考。
  • 多数会员采用三个月最短注射间隔及术前三个月等待,但注射次数上限与激素配方尚无统一标准。

局限性

  • 回复率仅22.7%(537/2365),可能存在无应答偏倚。
  • 调查基于会员自报实践与认知,非客观临床数据。
  • 原文未报告注射次数上限、疗效评价及并发症率的具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Knee osteoarthritis nonoperative management options remain limited. Our aim is to define the current American Association of Hip and Knee Surgeons (AAHKS) members' practices and perceptions in terms of the frequency, formulation, use of concomitant aspiration, maximum lifetime number of injections, efficacy, interval between injection and surgery and complication rates. METHODS: A 22-question survey based on Likert scale response anchors was approved and distributed by the AAHKS Research Committee to its membership by email during the Spring 2019 meeting. Data were managed with REDCap software. RESULTS: Membership response totaled 537 of 2365 (22.7%) members. Highlights include every respondent using intra-articular corticosteroid injections (ICIs) in their practice, and most use a three-month minimum interval, although the preferred interval is longer. Near consensus was found waiting three months before surgery. There was a great variability in the number of injections allowed, and injections before surgery were very common. Nearly all responders use a local anesthetic mixture with the cortisone injection, but there was great variation in corticosteroid type: methylprednisolone (42%), triamcinolone (41%), betamethasone (13.3%), and dexamethasone (3.7%). CONCLUSION: The results of our survey indicate the majority of the AAHKS members who completed the survey use ICIs routinely for treatment of knee osteoarthritis. There was near consensus in ICIs, which is effective with decreasing efficacy over serial injections, and an absolute minimum interval between injections was believed by most to be three months with no clearly defined lifetime limit and strong consensus for a three-month preoperative interval. The formulation of steroid, local anesthetic, and skin preparation technique varied greatly.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Blankstein M, Lentine B, Nelms NJ, et al. Common Practices in Intra-Articular Corticosteroid Injection for the Treatment of Knee Osteoarthritis: A Survey of the American Association of Hip and Knee Surgeons Membership. J Arthroplasty. 2020. PMID: 33616067. doi:10.1016/j.arth.2020.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。